Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2003
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084964A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084464A2 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
10/16/2003WO2003068247B1 Eye installation based on iodine anions
10/16/2003WO2003066030A3 Pharmaceutical tablet
10/16/2003WO2003051313A3 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
10/16/2003WO2003043668A3 Conditioning solution for contact lenses
10/16/2003WO2003039575A3 Use of reelin, gas6, and protein s in the treatment of neural disorders
10/16/2003WO2003039231A3 Compounds and methods for treating transplant rejection
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003024993A3 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
10/16/2003WO2003013427A3 A method for preparing fluticasone derivatives
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/16/2003WO2002060473A3 Method for treatment of diabetic retinopathy with naturally occurring insulin-like growth factors (igfs) and igf analogs
10/16/2003WO2002056804A3 Presbyopia treatment by lens alteration
10/16/2003WO2002036151A3 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
10/16/2003US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195235 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195198 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
10/16/2003US20030195181 Laulimalide derivatives
10/16/2003US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates
10/16/2003US20030195172 Novel phosphonic acid compounds as inhibitors of serine proteases
10/16/2003US20030195160 Sodium channel blockers
10/16/2003US20030195157 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof
10/16/2003US20030194441 Antibacterial aqueous solutioncomprises: methylcellulose; citric acid; polyethylene glycol and an active drug component, especially a quinolone antibiotic; viscosity of 12 mPa.s or below at 20 degrees C.
10/16/2003US20030194421 Treatment of uveitis
10/16/2003US20030194404 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481463A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2479927A1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2462708A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/15/2003EP1352903A1 Preventive or remedial agent for allergic disease and medical water-based liquid preparation, eye drop, and nasal drop
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
10/15/2003EP1351962A2 Thienopyrimidine
10/15/2003EP1351958A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351693A1 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0950047B1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
10/15/2003CN1449446A Streptococcus antigens
10/15/2003CN1449398A 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1h)one derivatives
10/15/2003CN1449396A Carbamates derived from arylalkylamines
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449386A Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1449285A Use of il-8 receptor antagonists in the treatment of virus infections
10/15/2003CN1449284A 维生素c组合物 Vitamin c composition
10/15/2003CN1448137A Gatifloxacin external and ophthalmic gel preparation
10/15/2003CN1124255C Inhibition of matrix metalloproteases by substituted phenethyl compounds
10/14/2003US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/14/2003US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632798 Methods for inhibiting angiogenesis
10/14/2003US6632423 To prevent or reduce fibrosis and/or adhesion in traumatized tissues, comprising the administration of a stabilizing effective amount of the agent to the traumatized tissue
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/09/2003WO2003082893A2 Theraputic methods and uses of sapogenins and their derivatives
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082867A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
10/09/2003WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082837A1 Hydroxymorpholinone derivative and medicinal use thereof
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082825A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 531